Get Fit Bharat

Tag: Gym

HomeGym

Wallenstam’s initiative involving reuse, green leases and full-service offices ready for occupation at Kaserntorget 6 has been highly sought after. Recently, Prodesign signed an agreement for the last premises of 460 square meters and will move in during January next year. This means that the entire property of about 2,000 square …

Kesko has updated its sustainability strategy, setting emission reduction targets for its own operations extending to 2034. Over the next 10 years, Kesko will be increasing its investments in energy efficiency and the electrification of transports in an effort to reduce emissions. In the updated strategy, Kesko has also placed increased …

​ Diageo India (United Spirits Ltd.), among the country’s leading alco-bev companies, launched its third annual ESG Reporting Index 2024 today, highlighting continued progress in the company’s ‘Spirit of Progress’ ESG action plan. The Reporting Index shares impacts across three key objectives outlined in Diageo’s Spirit of Progress plan, this includes pioneering grain-to-glass sustainability, promoting …

Singapore:  OCBC and Ant International have formed a strategic partnership to enhance the efficiency and speed of cross-border fund settlements. In a Memorandum of Understanding (MoU) signed on 5 November 2024 by Melvyn Low, Head of Global Transaction Banking at OCBC,and Douglas Feagin, President of Ant International, both parties agreed to …

The order of precedence in India is an official listing that ranks high-profile officials and dignitaries according to their constitutional roles and protocol significance. This hierarchy is crucial for organizing state events, determining seating arrangements, and extending formal courtesies. While this precedence defines relative importance for ceremonial purposes, it doesn’t grant any legal authority or …

Stockholm, November 5, 2024: Immedica announces today that the Biologics License Application (BLA) for pegzilarginase in the treatment of arginase 1 deficiency (ARG1-D) has been successfully validated and accepted for priority review by the U.S. Food and Drug Administration (FDA). Anders Edvell, CEO of Immedica commented: “We are pleased that …